BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12818869)

  • 1. A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings.
    Damascelli B; Patelli GL; Lanocita R; Di Tolla G; Frigerio LF; Marchianò A; Garbagnati F; Spreafico C; Tichà V; Gladin CR; Palazzi M; Crippa F; Oldini C; Calò S; Bonaccorsi A; Mattavelli F; Costa L; Mariani L; Cantù G
    AJR Am J Roentgenol; 2003 Jul; 181(1):253-60. PubMed ID: 12818869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and efficacy of percutaneous transcatheter intraarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx.
    Damascelli B; Patelli G; Tichá V; Di Tolla G; Frigerio LF; Garbagnati F; Lanocita R; Marchianò A; Spreafico C; Mattavelli F; Bruno A; Zunino F
    J Vasc Interv Radiol; 2007 Nov; 18(11):1395-403. PubMed ID: 18003990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA; Ilson DH; Kelsen DP
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial.
    Cmelak AJ; Murphy BA; Burkey B; Douglas S; Shyr Y; Netterville J
    Head Neck; 2007 Apr; 29(4):315-24. PubMed ID: 17252600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy.
    Hancock SB; Krempl GA; Canfield V; Bogardus C; Kojouri K; Kaneaster SK; Medina JE
    Laryngoscope; 2008 Aug; 118(8):1357-61. PubMed ID: 18528311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007): Phase I study of patients with squamous cell carcinoma of the head and neck and anal canal: preliminary evidence of clinical activity.
    Damascelli B; Cantù G; Mattavelli F; Tamplenizza P; Bidoli P; Leo E; Dosio F; Cerrotta AM; Di Tolla G; Frigerio LF; Garbagnati F; Lanocita R; Marchianò A; Patelli G; Spreafico C; Tichà V; Vespro V; Zunino F
    Cancer; 2001 Nov; 92(10):2592-602. PubMed ID: 11745194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver.
    Camacho LH; Kurzrock R; Cheung A; Barber DF; Gupta S; Madoff DC; Wallace MJ; Kim EE; Curley SA; Hortobagyi GN; Mavligit G
    Cancer; 2007 Jun; 109(11):2190-6. PubMed ID: 17464952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity of paclitaxel in gastrointestinal tumors.
    Ajani JA; Ilson DH; Kelsen DP
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):46-50; discussion 51-3. PubMed ID: 7481861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
    Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Forastiere A; Arquette M; Costa F; Heelan R; Huang Y; Kelsen DP
    Cancer J; 2000; 6(5):316-23. PubMed ID: 11079171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series.
    Sturgis EM; Moore BA; Glisson BS; Kies MS; Shin DM; Byers RM
    Head Neck; 2005 Sep; 27(9):748-56. PubMed ID: 16086413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma.
    Papadimitrakopoulou VA; Ginsberg LE; Garden AS; Kies MS; Glisson BS; Diaz EM; Clayman G; Morrison WH; Liu DD; Blumenschein G; Lippman SM; Schommer D; Gillenwater A; Goepfert H; Hong WK
    Cancer; 2003 Nov; 98(10):2214-23. PubMed ID: 14601092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
    Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment results of continuous intra-arterial CBDCA infusion chemotherapy in combination with radiation therapy for locally advanced tongue cancer.
    Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jun; 105(6):714-9. PubMed ID: 18439857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma.
    Adamo V; Ferraro G; Pergolizzi S; Sergi C; Laudani A; Settineri N; Alafaci E; Scimone A; Spano F; Spitaleri G
    Oral Oncol; 2004 May; 40(5):525-31. PubMed ID: 15006626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase I study.
    Vogt HG; Kolotas C; Martin T; Schneider LV; Goes-Schmieder R; Mitrou PS; Diergarten K; Kober B; Zamboglou N
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):120-3. PubMed ID: 9007138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial.
    Gatzemeier U; Heckmayer M; Neuhauss R; Schlüter I; von Pawel J; Wagner H; Dreps A
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):24-8. PubMed ID: 8643966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.